Compare PAHC & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | BUR |
|---|---|---|
| Founded | 1946 | 2009 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2014 | 2010 |
| Metric | PAHC | BUR |
|---|---|---|
| Price | $52.26 | $9.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $34.33 | $18.00 |
| AVG Volume (30 Days) | 297.5K | ★ 1.7M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | 0.92% | ★ 1.33% |
| EPS Growth | ★ 373.98 | N/A |
| EPS | ★ 2.26 | 0.40 |
| Revenue | ★ $1,464,325,000.00 | $466,134,000.00 |
| Revenue This Year | $15.34 | $13.60 |
| Revenue Next Year | $3.28 | $10.53 |
| P/E Ratio | ★ $23.12 | $23.63 |
| Revenue Growth | ★ 32.39 | N/A |
| 52 Week Low | $16.16 | $8.19 |
| 52 Week High | $56.30 | $15.73 |
| Indicator | PAHC | BUR |
|---|---|---|
| Relative Strength Index (RSI) | 72.49 | 50.47 |
| Support Level | $50.94 | $9.03 |
| Resistance Level | $52.89 | $9.57 |
| Average True Range (ATR) | 2.26 | 0.32 |
| MACD | 1.04 | -0.03 |
| Stochastic Oscillator | 77.30 | 53.72 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.